All Posts: cancer
-
Mouse Study Mirrors Human Findings That Link Chemotherapy and APOE4 to Cognitive Issues
New research by Georgetown University Medical Center investigators indicates that a chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, which is known to significantly increase the risk of developing Alzheimer’s disease.
Category: News Release
-
First Large Study Details Cognitive Outcomes Among Older Breast Cancer Patients
The first large U.S. study of cognition in older breast cancer patients, led by researchers from Georgetown Lombardi Comprehensive Cancer Center, indicates that within the first two years after diagnosis and treatment, most women do not experience cancer-related cognitive problems.
Category: News Release
-
Animal Study Suggests Deep Space Travel May Significantly Damage GI Function in Astronauts
Simulations with animal models meant to mirror galactic cosmic radiation exposure to astronauts are raising red flags for investigators at Georgetown University Medical Center about the health of astronauts during long voyages, such as to Mars.
Category: News Release
-
Georgetown Breast Cancer Advocates Make Their Case in Cancer Research Journal
A group of breast cancer advocates at Georgetown Lombardi Comprehensive Cancer Center says they’ve created a model for developing productive, successful and sustainable collaborations between advocates and scientists in cancer research.
Category: News Release
-
Acclaimed Breast Oncologist/Researcher Returns to Georgetown’s Cancer Center
Physician-scientist Marc E. Lippman, MD, MACP, FRCP, rejoins Georgetown Lombardi Comprehensive Cancer Center as a member of the breast cancer program and will also be a professor in the departments of oncology and medicine at Georgetown University Medical Center.
Category: News Release
-
Exciting Research Finding Ushers in New Era in Breast Cancer Treatment
Definitive results from a large international breast cancer study that included Georgetown Lombardi Comprehensive Cancer Center show that a genetic test can help determine the course of a woman’s treatment and will ultimately spare many women with the most common subtype of breast cancer from receiving chemotherapy.
Category: Lombardi Stories
-
Family History Increases Breast Cancer Risk Even in Older Women: Weighing Screening Options
Family history of breast cancer continues to significantly increase chances of developing invasive breast tumors in women ages 65 and older, according to research published by a team led by Dejana Braithwaite, PhD, associate professor of oncology at Georgetown University School of Medicine and a member of Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Georgetown Lombardi’s Jeffrey Toretsky, MD, Named a National Academy of Inventors Fellow
The National Academy of Inventors has named Jeffrey Toretsky, MD, a pediatric oncologist and researcher at Georgetown Lombardi Comprehensive Cancer Center, to its 2017 class of fellows.
Category: News Release
-
New Test Provides Accurate Measure of DNA Damage from Chemical Compounds
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Category: News Release
-
On Capitol Hill, Weiner Advocates for Investments in Cancer Research
The future of cancer care depends on continued federal funding for medical research, Louis M. Weiner, MD, director of Georgetown Lombardi Comprehensive Cancer Center, said during a panel discussion in front of a crowded room on Capitol Hill on June 29.
Category: Lombardi Stories